2,280
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: RADIOTHERAPY

Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers

ORCID Icon, , , , , , , , , , , & show all
Pages 943-950 | Received 10 Aug 2018, Accepted 21 Feb 2019, Published online: 25 Mar 2019

References

  • van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084.
  • Van Westreenen HL, Westerterp M, Bossuyt PMM, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. JCO. 2004;22:3805–3812.
  • Muijs CT, Beukema JC, Pruim J, et al. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol. 2010;97:165–171.
  • Thomas L, Lapa C, Bundschuh RA, et al. Tumour delineation in oesophageal cancer – a prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiother Oncol. 2015;116:269–275.
  • Nowee ME, Voncken FEM, Kotte ANTJ, et al. Gross tumour delineation on Computed Tomography and Positron Emission Tomography-Computed Tomography in oesophageal cancer: a nationwide study. Clin Transl Radiat Oncol. 2018;14:33–39.
  • Gaur P, Sepesi B, Hofstetter WL, et al. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer. 2011;117:63–69.
  • Wang B, Liu C, Lin C, et al. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol. 2012;19:2149–2158.
  • MacHiels M, Van Hooft J, Jin P, et al. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers. Gastrointest. Endosc. 2015;82:641–649.
  • DiMaio CJ, Nagula S, Goodman K. a, et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc. 2010;71:1204–1210.
  • Fernandez DC, Hoffe SE, Barthel JS, et al. Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy. Pract Radiat Oncol. 2013;3:32–39.
  • Machiels M, van Montfoort ML, Thuijs NB, et al. PO-0812: Pathological validation of endoscopically placed fiducials on tumor borders in esophageal cancer. Radiother Oncol. 2019;133.
  • Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17:1721–1724.
  • Kruis MF, Van De Kamer JB, Sonke JJ, et al. Registration accuracy and image quality of time averaged mid-position CT scans for liver SBRT. Radiother Oncol. 2013;109:404–408.
  • Steenbakkers RJHM, Duppen JC, Fitton I, et al. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a “Big Brother” evaluation. Radiother. Oncol. 2005;77:182–190.
  • Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol. 2009;54:2863–2873.
  • R Core Team. R: A language and environment for statistical computing. Vienna, Austria: The R Foundation for Statistical Computing; 2013.
  • Bates D, Mächler M, Bolker B, et al. Fitting linear mixed-effects models using lme4. J Statsitcal Softw 2015;67:51.
  • Fotina I, Lütgendorf-Caucig C, Stock M, et al. Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy. Strahlenther Onkol. 2012;188:160–167.
  • Gwynne S, Spezi E, Wills L, et al. Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. Int J Radiat Oncol Biol Phys. 2012;84:1037–1042.
  • Anon. Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol. 1998;42:277–288.
  • Deurloo KEI, Steenbakkers RJHM, Zijp LJ, et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005;61:228–238.
  • van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14:52–64.
  • Jin P, van der Horst A, de Jong R, et al. Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer. Radiother Oncol. 2015;117:412–418.
  • Jin P, Hulshof MCCM, de Jong R, et al. Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography. Radiother Oncol. 2016;118:492–497.
  • Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997;39:841–848.
  • den Hartogh MD, Philippens MEP, van Dam IE, et al. MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy. Radiat Oncol. 2014;9:63.
  • Gurney-Champion OJ, Versteijne E, van der Horst A, et al. Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study. Acta Oncol. 2017;56:923–930.
  • Hou D-L, Shi G-F, Gao X-S, et al. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma. Radiat Oncol. 2013;8:169.
  • Gurney-Champion OJ, van Tienhoven G, et al. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. Med Phys. 42:2638–2647.